Angela Rampa
Overview
Explore the profile of Angela Rampa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
684
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Orioli R, Belluti F, Gobbi S, Rampa A, Bisi A
Molecules
. 2024 Aug;
29(15).
PMID: 39124919
The main feature of neurodegenerative diseases, including Alzheimer's disease, is the network of complex and not fully recognized neuronal pathways and targets involved in their onset and progression. The therapeutic...
2.
Gobbi S, Martini S, Rozza R, Spinello A, Caciolla J, Rampa A, et al.
Molecules
. 2023 Apr;
28(7).
PMID: 37049810
Despite the significant outcomes attained by scientific research, breast cancer (BC) still represents the second leading cause of death in women. Estrogen receptor-positive (ER+) BC accounts for the majority of...
3.
Hitting drug-resistant malaria infection with triazole-linked flavonoid-chloroquine hybrid compounds
Seghetti F, Belluti F, Rampa A, Gobbi S, Legac J, Parapini S, et al.
Future Med Chem
. 2023 Jan;
14(24):1865-1880.
PMID: 36622669
: Malaria represents the major parasitic disease in tropical regions, and the development of new potent drugs is of pivotal importance. In this study, a series of hybrid molecules were ...
4.
Bisi A, Feoli A, Trezza A, Viejo L, Formaggio F, Bartolini M, et al.
Bioorg Chem
. 2022 Sep;
129:106152.
PMID: 36155094
The complexity of neurodegenerative diseases, among which Alzheimer's disease plays a pivotal role, poses one of the tough therapeutic challenges of present time. In this perspective, a multitarget approach appears...
5.
Seghetti F, Gobbi S, Belluti F, Rampa A, Bisi A
Curr Med Chem
. 2021 Nov;
29(28):4796-4830.
PMID: 34781863
Pharmacological treatment of complex pathologies, such as neurodegenerative diseases still represents a major challenge, due to the networked pathways involved in their onset and progression that may require equally complex...
6.
Caciolla J, Martini S, Spinello A, Pavlin M, Turrini E, Simonelli F, et al.
Eur J Med Chem
. 2021 Aug;
224:113733.
PMID: 34364162
Breast Cancer (BC) is a leading cause of death in women, currently affecting 13% of female population worldwide. First-line clinical treatments against Estrogen Receptor positive (ER+) BC rely on suppressing...
7.
Gobbi S, Belluti F, Rampa A, Bisi A
Molecules
. 2021 Jul;
26(14).
PMID: 34299503
Naturally occurring flavonoids are found as secondary metabolites in a wide number of plants exploited for both medicine and food and have long been known to be endowed with multiple...
8.
Montanari S, Allara M, Scalvini L, Kostrzewa M, Belluti F, Gobbi S, et al.
Molecules
. 2021 Jun;
26(11).
PMID: 34071439
In the last years, the connection between the endocannabinoid system (eCS) and neuroprotection has been discovered, and evidence indicates that eCS signaling is involved in the regulation of cognitive processes...
9.
Caciolla J, Picone G, Farruggia G, Valenti D, Rampa A, Malucelli E, et al.
Bioorg Chem
. 2020 Nov;
106:104460.
PMID: 33229118
A small library of derivatives carrying a polycyclic scaffold recently identified by us as a new privileged structure in medicinal chemistry was designed and synthesized, aiming at obtaining potent MDR...
10.
Caciolla J, Bisi A, Belluti F, Rampa A, Gobbi S
Molecules
. 2020 Nov;
25(22).
PMID: 33207783
The current therapeutic approach for the treatment of hormone dependent breast cancer includes interference with estrogen receptors via either selective modulators or estrogens deprivation, by preventing their biosynthesis with aromatase...